Intermountain is developing an innovative device concept for in-situ destruction of unresectable tumors. The innovation is the development of a tumor ablation device with a flexible heating surface. These heating blanket-like devices partially envelop surgically isolated tumors for heat ablation treatment. The device can be incorporated into a flexible wrap or as part of a surgical glove. Heat ablation surgery has been used for many years using hand held wand-type devices or probes for delivering heat to the inside of a tumor. Existing probe/wand devices can require excessive temperatures and treatment times to effectively treat the growing cancer cells on the outer perimeter of the tumor. An outer surface heat ablation device takes advantage of a surgeon’s ability to isolate the tumor from healthy tissue and the ability to define heating boundaries in an open surgical setting. The same cancer cell killing mechanisms used by heat ablation probes can be optimally applied to treat a tumor with tighter control as part of a surgical procedure. It is estimated that 40% of all people born in the US will be diagnosed with cancer during their lifetime. It is estimated that one million people annually develop tumors that interact with highly vascularized organs or critical tissue structures. Of these, about 100,000 will have unresectable tumors that may benefit from the use of this proposed Flexible Tumor Ablation Device. A patent application has been filed, which has published as WO2012068580. For further information on this product concept, please contact Mike Mayer, mike.mayer@imail.org, 801-408-1095.